Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840061
mi
from
Traverse City, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840061
mi
from
Traverse City, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840076
mi
from
Minneapolis, MN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840076
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840079
mi
from
Tupelo, MS
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840079
mi
from
Tupelo, MS
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840310
mi
from
St. Louis, MO
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840310
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840060
mi
from
Syracuse, NY
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840060
mi
from
Syracuse, NY
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840029
mi
from
Charlotte, NC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840029
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840074
mi
from
Bismarck, ND
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840074
mi
from
Bismarck, ND
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840005
mi
from
Cincinnati, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840005
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840078
mi
from
Dayton, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840078
mi
from
Dayton, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840133
mi
from
Tulsa, OK
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840133
mi
from
Tulsa, OK
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840257
mi
from
Portland, OR
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840257
mi
from
Portland, OR
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840004
mi
from
Philadelphia, PA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840004
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840068
mi
from
Greenville, SC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840068
mi
from
Greenville, SC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840071
mi
from
Cordova, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840071
mi
from
Cordova, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840001
mi
from
Nashville, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840001
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840186
mi
from
San Antonio, TX
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840186
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840006
mi
from
Bennington, VT
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840006
mi
from
Bennington, VT
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840020
mi
from
Charleston, WV
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840020
mi
from
Charleston, WV
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 036005
mi
from
Bedford Park,
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 036005
mi
from
Bedford Park,
Click here to add this to my saved trials
Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis
Examining the Effects of Dance, Dance Revolution on Mobility, Brain Plasticity and Cognition in Individuals With Multiple Sclerosis
Status: Enrolling
Updated:  9/2/2015
The Ohio State University Atwell Hall
mi
from
Columbus, OH
Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis
Examining the Effects of Dance, Dance Revolution on Mobility, Brain Plasticity and Cognition in Individuals With Multiple Sclerosis
Status: Enrolling
Updated: 9/2/2015
The Ohio State University Atwell Hall
mi
from
Columbus, OH
Click here to add this to my saved trials
Single-Dose Study of a New Formulation of BIIB061
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Madison, WI
Single-Dose Study of a New Formulation of BIIB061
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
OrthoArkansas, P. A.
mi
from
Little Rock, AR
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
OrthoArkansas, P. A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Orthoarkansas
mi
from
Little Rock, AR
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Orthoarkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Patricia Fodor
mi
from
Colorado Springs, CO
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Patricia Fodor
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Meridien Research
mi
from
Tampa, FL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
MS Center of Atlanta
mi
from
Atlanta, GA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
MS Center of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Elkhardt Clinic
mi
from
Elkhart, IN
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Elkhardt Clinic
mi
from
Elkhart, IN
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Springfield Neurology
mi
from
Springfield, MA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Springfield Neurology
mi
from
Springfield, MA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
General Clinical Research Center 7A
mi
from
Ann Arbor, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
General Clinical Research Center 7A
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Medex Healthcare Research, Inc.
mi
from
St. Louis, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Medex Healthcare Research, Inc.
mi
from
St. Louis, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Northern Michigan Neurology
mi
from
Traverse City, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Northern Michigan Neurology
mi
from
Traverse City, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Winthrop University Hospital
mi
from
Mineola, NY
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Crozer-Chester Medical Center
mi
from
Upland, PA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Crozer-Chester Medical Center
mi
from
Upland, PA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Integra Clinical Research
mi
from
San Antonio, TX
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Integra Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
The Neurological Research center, Inc
mi
from
Bennington, VT
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
The Neurological Research center, Inc
mi
from
Bennington, VT
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
VCU Medical Center
mi
from
Richmond, VA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Montreal Neurological Institute and Hospital
mi
from
Montreal,
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Montreal Neurological Institute and Hospital
mi
from
Montreal,
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Balance Disorders Clinic
mi
from
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Balance Disorders Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated:  10/15/2015
Fitness and Wellness Center
mi
from
Tallahassee, FL
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease
Status: Enrolling
Updated: 10/15/2015
Fitness and Wellness Center
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Tanner Center and Foundation for MS
mi
from
Birmingham, AL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Tanner Center and Foundation for MS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
The Neurology Center
mi
from
Oceanside, CA
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
The Neurology Center
mi
from
Oceanside, CA
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
McCare Center Neurology Services
mi
from
Orlando, FL
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
McCare Center Neurology Services
mi
from
Orlando, FL
Click here to add this to my saved trials
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated:  10/21/2015
Neurology Center of Fairfax
mi
from
Fairfax, VA
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study
Status: Enrolling
Updated: 10/21/2015
Neurology Center of Fairfax
mi
from
Fairfax, VA
Click here to add this to my saved trials